Indeed, 30.0 % of Scrib+/+ and 13.3 % of Scrib+/fl mice remained tumor-free during the course of the experiment (Fig. 5b), however overall survival was not significantly different between genotypes (Additional file 3: Figure S3A). This evidence concerns the gene SCRIB and neoplasm.